| Literature DB >> 24847348 |
Ryo Koda1, Atsunori Yoshino1, Yuji Imanishi1, Shinya Kawamoto1, Yoshihiko Ueda2, Junichiro James Kazama3, Ichiei Narita3, Tetsuro Takeda1.
Abstract
Glomerulonephropathy is a rare complication of Takayasu's arteritis (TA). To date, most glomerulonephropathies associated with TA show the histological feature of mesangial proliferation. Membranous glomerulonephropathy (MG) is a form of glomerulonephropathy in which the mesangial proliferation is not conspicuous and its association with TA is extremely rare. A 54-year-old man was referred to our hospital due to progressive edema in the lower limbs and nephrotic range proteinuria. Five years previously, he underwent percutaneous angioplasty for left subclavian artery stenosis. Kidney biopsy revealed stage II MG. General examination including enhanced CT scan confirmed the presence of TA. He started oral prednisolone therapy at a dose of 40 mg daily. The C-reactive protein level normalized 7 days after the prednisolone therapy. Three months later, proteinuria had remitted. Though the true relationship between MG and TA was not revealed in present case, considering the fact that complete remission of nephrotic syndrome occurred following the improvement of C-reactive protein level in response to steroid therapy, TA might be the secondary cause of MG. To our best knowledge, only two case reports described the association of MG and TA previously. Those two patients, however, also demonstrated the feature of systemic lupus erythematosus in addition to TA. This is the first case report that describes a patient who presented as MG associated with TA, but not complicated by systemic lupus erythematosus.Entities:
Keywords: Aortitis syndrome; Membranous glomerulonephropathy; Nephrotic syndrome; Systemic lupus erythematosus; Takayasu's arteritis
Year: 2014 PMID: 24847348 PMCID: PMC4025153 DOI: 10.1159/000360850
Source DB: PubMed Journal: Case Rep Nephrol Urol ISSN: 1664-5510
Fig. 1Microscopic findings. a Periodic acid-Schiff staining. ×200. The glomeruli are hypertrophic, but thickening of the GBM is not apparent. A mild increase in mesangial matrix is occasionally noted, but mesangial cell proliferation is not obvious. b Periodic acid methenamine silver staining, ×200. c Magnified view of b, ×400. Spike formation or bubble-like appearance on the capillary walls is not apparent. d Electron microscopic findings. Irregular thickening of the GBM with diffuse subepithelial immune deposits (arrowheads) is observed along the entire capillary wall. Projection of the GBM (arrows) is noted between adjacent immune deposits, compatible with stage II MG. Intramembranous and subendothelial immune deposits are not apparent.
Fig. 2Immunofluorescence. Diffuse, granular patterns of IgG deposits are observed along the capillaries. Staining intensity of IgG1 and IgG4 is predominant, whereas IgG2 shows weak intensity. Deposition of IgG3 was negative (not shown).
Fig. 3Clinical course. Percutaneous angioplasty for left subclavian artery stenosis was performed 5 years previously. Proteinuria was detected 4 months before admission. Kidney biopsy showed stage II MG and three-dimensional CT angiography confirmed the presence of TA. Oral PSL was initiated at a dose of 40 mg daily. CRP was normalized 7 days after the initiation of PSL therapy. Proteinuria decreased gradually. Three month later, proteinuria became <0.15 g/gCr. Eighteen months later, nephrotic syndrome and TA remain remitted with 5 mg PSL daily. During the clinical course, CRP increased twice due to colds. UP/UCr = Urinary protein to creatinine ratio.
Fig. 4a Three-dimensional CT angiography showed diffuse stenosis in the aortic arch and primary branches (arrowheads). A stent was placed in the proximal portion of the left subclavian artery (arrow). b A sagittal CT scan showed a thickened wall along the thoracic aorta (arrows). c CT scan before treatment. The abdominal aorta showed diffuse wall thickening (arrow). d One year after the PSL therapy, wall thickening was improved (arrow).
Three cases of MG associated with TA
| Case 1 | Case 2 | Case 3 | |
| Age/gender | 61 years/F | 47 years/F | 54 years/M |
| Age at onset of TA | 38 years | 47 years | 45–50 years |
| Affected arteries | left subclavian artery, left vertebral artery | left pulmonary artery, abdominal aorta, right renal artery | left subclavian artery, ascending to abdominal aorta, brachiocephalic trunk and bilateral vertebral arteries |
| Complication | SLE [anemia, leukopenia, lymphopenia, ANA (+), hypocomplementemia, anti-DNA antibody (+), urinary protein (3+), lupus band test (+)] | SLE suspicion [ANA (+), anti-DNA antibody 39.7 U/ml, urinary protein (3+)] | dyslipidemia |
| Kidney function | sCr: normal | sCr: 0.8 mg/dl | sCr: 0.6 mg/dl |
| Urinary protein | 1.7 g/day | (3+) | 11.1 g/day |
| Hematuria | (–) | (+/–) | (–) |
| CRP | high | <1.0 mg/dl | 1.23 mg/dl |
| ESR | elevated | 58 mm/h | 109 mm/h |
| Kidney biopsy | class II lupus nephritis with podocytic infolding associated with TA | glomerulonephropathy mimicking lupus membranous nephropathy | MG (stage II) |
| Light microscopy | GS: | GS: 3/23, spike (+), mesangial matrix and cell proliferation (+) | GS: 2/19, spike (–), slight increase in mesangial matrix, mesangial cell proliferation (–) |
| Immunofluorescence | granular deposits of IgG, IgM, C1q in capillary and mesangial lesion, IgG subclass: not assessed | granular deposits of IgG, IgA, IgM, C1q, C3 in the capillary wall and mesangial lesion, IgG subclass: not assessed | granular deposits of IgG in capillary wall, IgG subclass: IgG1 (2+), IgG2 (+), IgG3 (–), IgG4 (2+) |
| Electron microscopy | subepithelial, intramembranous and mesangial deposits (podocyte infolding glomerulopathy) | subepithelial and mesangial deposits | subepithelial deposits |
| Treatment | PSL 40 mg + CyA 100 mg | PSL 40 mg | |
| Course | urinary protein <1.0 g/day | urinary protein (–), CRP <1.0 mg/dl | |
| Reference | Kitazawa et al. [ | Nakashima et al. [ | present case |
ANA = Anti-nuclear antibody; CCR = creatinine clearance rate; CyA = cyclosporine; ESR = erythrocyte sedimentation rate; GS = glomerulosclerosis; sCr = serum creatinine.
* Value not described.
** Not described.